Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy

Mineralocorticoid receptor antagonists (MRAs) slow cardiomyopathy in patients with Duchenne muscular dystrophy (DMD) and improve skeletal muscle pathology and function in dystrophic mice. However, glucocorticoids, known antiinflammatory drugs, remain a standard of care for DMD, despite substantial s...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Zachary M. Howard, Chetan K. Gomatam, Charles P. Rabolli, Jeovanna Lowe, Arden B. Piepho, Shyam S. Bansal, Federica Accornero, Jill A. Rafael-Fortney
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	American Society for Clinical investigation 2022-10-01
Ráidu:	JCI Insight
Fáttát:	Muscle biology
Liŋkkat:	https://doi.org/10.1172/jci.insight.159875
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!